Pfizer/Seagen Merger Seems Set To Clear As US FTC Sticks To Traditional Review

 
• By Brenda Sandburg

Pink Sheet infographic breaks down the big pharma deals and required divestitures over the past four years. Seagen reports that Pfizer's acquisition of the company is expected to close late this year or in early 2024.

M&A magnifying glass
FTC review of pharma M&A deals is not leading to divestitures • Source: Shutterstock

More from Compliance

More from Pink Sheet